-
Recent Posts
- NHS Demands Action to Reduce Betting-Related Ill Health (BBC News / NHS England / Respublica)
- Research and Innovation Across the NHS and Academia (BBC News / Academy of Medical Sciences)
- eHealth / Internet-Based Interventions to Support Carers of People With Dementia (Internet Interventions)
- Christmas and Dementia: Some Benefits and Coping Strategies (BBC News / NHS England)
- Review of Tube Feeding in Advanced Dementia (Journal of Aging Research)
Archives
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Imaging
Summary of Recent Progress in Alzheimer’s Disease Prevention Trials (CTAD / JPAD)
Summary The following article summarises a round-up of present understanding and developments reflected in current and planned prevention trials, as discussed at a EU / US / Clinical Trials in Alzheimer’s Disease (CTAD) Task Force meeting, as of December 2016-7. … Continue reading →
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights
|
Tagged Accelerating Alzheimer's Research and Drug Development, Alzheimer's Disease Co-operative Study - Activities of Daily Living Scale (ADCS-ADL), Alzheimer’s Disease Prevention Trials, Alzheimer’s Prevention Initiative (API), Alzheimer’s Prevention Initiative Study, Alzheimer’s Therapeutic Research Institute (ATRI), Amsterdam IADL Questionnaire, Amyloid and Tau Imaging, Amyloid and Tau PET, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study, Banner Alzheimer's Institute (Arizona), Biological Markers, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brigham and Women's Hospital, Canada, CHU Toulouse (France), Cognitive Function Instrument, Cognitive Outcome Measures, Cogstate iPad C3 Battery, Collaboration for Alzheimer’s Prevention (CAP), Composite Measures (sic Cognitive Composites), Conversion to Dementia From Prodromal Disease, Dementia Prevention, Dementia Research and Drug Development, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Denali Therapeutics (South San Francisco), Department of Epidemiology and Public Health: CHU Toulouse, DIAN-TU Study, DIAN-TU Trial, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU), Drug Development for Alzheimer's Disease, Drug-Development Pipeline, EU/US/Clinical Trials in Alzheimer's Disease (CTAD) Task Force, EU/US/Clinical Trials in Alzheimer's Disease (CTAD) Task Force (December 2016 Meeting), European Medicines Agency, Everyday Cognition (E-Cog) Scale, F-31073 (Toulouse), F. Hoffmann-LaRoche Ltd (Basel), France, Free and Cued Selective Reminding Test (FCSRT), Functional Activities Questionnaire (FAQ), Gerontopole Toulouse: Toulouse University Hospital, Global R&D Partners LLC (San Diego), Harvard Medical School, Imaging, Inc. (New York), Informant-Reported Outcome Measures, Innovation Infrastructure, Johns Hopkins University School of Medicine Baltimore, Journal of Prevention of Alzheimer’s Disease (JPAD), Keck School of Medicine: University of Southern California, Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) Study, McGill University, Molecular Imaging; Mild Behavioral Impairment, Multi-Domain Alzheimer’s Prevention Trial (MAPT), National Institutes of Health’s Accelerating Medicines Partnership (AMP), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neurology (FDA), Next Generation (NexGen) Prevention Trial, NIH Toolbox Cognition Battery (NIHTB-CB), Non-Invasive Biomarkers, Outcome Measures, Participation in Research, Patient Reported Outcome Measures, Pentara Corporation (Salt Lake City), PET, Pfizer, Plasma Biomarkers, Preclinical Alzheimer's Disease, Preclinical Alzheimer’s Cognitive Composite (PACC), Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Preclinical Indicators and Dementia, Preclinical Indicators in Alzheimer's Disease, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prodromal Alzheimer's Disease, Promisary Science, Recruitment and Retention, Regulation and Drug Development For Early-Stage Alzheimer's Disease, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Sharing Knowledge and Information, Slowing Progression of Disease (Stabilisation), Switzerland, Tau PET, Technology and Infrastructure Development, TOMMORROW Study, UMR1027 Inserm, United States, University College London, University Hospital of Montpellier, University of Southern California, University of Toulouse III, USA, Washington University School of Medicine
|
Leave a comment
Non-Alzheimer’s Dementias: Three Reviews (Lancet)
Summary The Lancet has published a series of three up-to-date reviews concerning non-Alzheimer’s dementia. Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access). Reference Dementia – not all about Alzheimer’s. [Editorial]. … Continue reading →
Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest
|
Tagged Akershus University Hospital and University of Oslo, Alzheimer's Disease Diagnostic and Treatment Centers (ADDTC), Alzheimer's Disease With Cardiovascular Disease, APOE e4 (Apolipoprotein E e4), ApoE e4 Allele, Association of RBD with Synucleinopathies, Behavioural Frontotemporal Dementia (bvFTD), Behavioural Variant Frontotemporal Dementia (bvFTD), Biomarkers, Brain Imaging, BV-FTD, C677T, C9orf72 MAPT and GRN Genes, Cambridge Biomedical Campus, Campus for Ageing and Vitality: Newcastle upon Tyne, Center for Sleep Medicine: Mayo Clinic, Center for Sleep Medicine: Mayo Clinic College of Medicine, Centre for Age-Related Diseases: Stavanger University Hospital, Cerebrovascular Disease, CeVD: Cerebrovascular Disease, Clinical Symptoms Characteristic of Frontotemporal Dementia, Cognitive Assessments / Screening Tools, Constipation, Delirium and Dementia With Lewy Bodies, Dementia with Lewy Bodies, Dementia With Lewy Bodies (DLB), Dementia with Lewy Bodies Symptoms, Department of Geriatric Psychiatry: Akershus University Hospital, Department of Neurology: Mayo Clinic College of Medicine, Department of Psychiatry: University of Cambridge, Diagnosis of Vascular Dementia, Differential Diagnosis, Differential Diagnosis of Memory Problems, Division of Psychiatry: University College London, DLB: Dementia with Lewy Bodies, Dopamine Transporter Single Photon Emission CT, Early Diagnosis, Epidemiology, Epidemiology and Statistics, Epidemiology of Frontotemporal Dementia, Epidemiology of Major Neurological Disorders, Fluctuating Cognition, Fluctuations, Fluorodeoxyglucose PET, Frontotemporal Dementia, Frontotemporal Dementia (FTD), Frontotemporal Dementia Symptoms, Frontotemporal Dementia With Motor Neurone Disease (FTD-MND), Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Lobar Degeneration FUS, FTLD: Frontotemporal Lobar Degeneration, Genetic and Pathological Correlation in FTLD, Genetics, Genetics of DLB, Haemorrhagic Dementia, Hallucinations, Hallucinations and Delusions in Parkinson's Disease, Hallucinations in People with Dementia, Hereditary Vascular Dementia (CADASIL), Hypoperfusion Dementia, Imaging, Increased Salivation, Institute of Neuroscience and Newcastle University Institute for Ageing: Newcastle University, Lancet, Lewy Body Dementia, Lewy Body Dementia (LBD), Lewy Body Dementia Symptoms Checklists, Management of Vascular Dementia, Mayo Clinic College of Medicine (USA), Memory and Aging Center: University of California, Mental Health Unit: St Margaret's Hospital (Epping), Mild Cognitive Impairment in Parkinson's Disease (MCI-PD), MTHFR, Multi-Infarct Dementia (Cortical Vascular Dementia), National Institute of Neurological Disorders and Stroke and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN), Neurological Disease, Neurological Disorders, Neuropathological Features, Neuropathology, Neuropathology in FTLD-tau and FTLD-TDP, Newcastle University, NFV-PPA, Non-Alzheimer’s Dementia, Non-Fluent Variant Primary Progressive Aphasia, Nondegenerative Neurological Diseases (NNDs), North Essex Partnership University NHS Foundation Trust, Norway, Norway Stavanger University Hospital, Nosology of Vascular Dementia, Olfactory Dysfunction, Parkinson’s Disease Dementia, Parkinsonism, Pathological Staging, Pick’s Disease (Frontotemporal Dementia), Positron Emission Tomography (PET), Prevalence of Cerebrovascular Disease, Prevalence of Neurological Disorders, Prodromal Dementia With Lewy Bodies, Rapid Eye Movement Sleep Behaviour Disorder (RBD), RBD: Rapid Eye Movement Sleep Behaviour Disorder, Sandler Neurosciences Center (San Francisco), Semantic Variant Primary Progressive Aphasia, Single Photon Emission Computed Tomography (SPECT), Small Vessel Arteriosclerosis, Small Vessel Dementia (Subcortical Vascular Dementia), SNCA and LRRK2 Genes, SPECT (Single Photon Emission Computed Tomography), Stavanger University Hospital, Stavanger University Hospital; Norway, Strategic Infarct Dementia, Subtypes of Vascular Dementia, SV-PPA, Systematic Reviews and Meta-Analyses, Timely Diagnosis, Treatments for Dementia With Lewy Bodies and Parkinson's Disease Dementia, United States, University College London, University of California, University of California: San Francisco School of Medicine, University of Cambridge, USA, VaD: Vascular Dementia, Vascular Dementia Symptoms, Visual Hallucinations
|
1 Comment
NHS Atlas of Variation (BBC News / NHS England / NHS Right Care / PHE)
Summary The NHS Atlas of Variation, produced by NHS England, NHS Right Care and Public Health England (PHE), compares service performance across over 200 local areas. This latest Atlas includes over 100 maps covering data, at the level of individual … Continue reading →
Posted in Acute Hospitals, BBC News, Commissioning, Community Care, Diagnosis, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Patient Care Pathway, Public Health England, Quick Insights, Standards, Statistics, Stroke, UK, Universal Interest
|
Tagged Adult Critical Care Clinical Reference Group (ACC CRG), Adult Critical Care Services, Antibiotic Prescribing in Primary Care, Antibiotic Stewardship, Assessment and Diagnosis, BBC Health News, British Society for Interventional Radiology (BSIR), British Society of Paediatric Gastroenterology and Hepatology and Nutrition (BSPGHAN), Cancer Research UK, Cancers and Tumours, Capacity Planning, Cardiovascular Science (ICS) at University College London (UCL), Care of Alcohol-Related Conditions, Care of Older People, Care Quality Commission (CQC), CCGs: Clinical Commissioning Groups, Child and Maternal Health Intelligence Network, Clinical Commissioning Groups (CCGs), Dartmouth Atlas of Health Care, Dementia Diagnosis, Diabetes Care, Diabetes Community Health Profiles, Diabetes Prevention, Diagnosis and Referral, Diagnosis at Primary Care Level, Diagnosis Rates, Diagnostic Imaging, Diagnostic Services Atlas, Diagnostic Testing Rates, Diagnostic Waiting Times, Emergency Care, Genetic Testing, Geographical Variations, Health and Care of Older People, Health and Social Care Information Centre (HSCIC), HSCIC: Health and Social Care Information Centre, Imaging, Imaging Services, Improvement Opportunities in Local Commissioning, Improving Value in Diagnostic Services, Infectious Diseases, Joint Advisory Group on GI Endoscopy (JAG), Local Authorities, Local Commissioning, Local Health Services: Variations, Local Variations, Mental Health Dementia and Neurology Intelligence Network (MHDNIN), Method for Variation Approach, MHDNIN: Mental Health Dementia and Neurology Intelligence Network, National Cancer Intelligence Network (NCIN), National Cardiovascular Health Intelligence Network (NCVIN), National Centre for Cardiovascular Preventions and Outcomes (NCCPO), National Child and Maternal Health Intelligence Network (ChiMat), National Diabetes Audit (NDA), National End of Life Care Intelligence Network (NEoLCIN), National Infection Service (PHE), National Institute for Cardiovascular Outcomes Research (NICOR), National Mental Health Dementia and Neurology Intelligence Network (NMHDNIN), National Paediatric Diabetes Audit (NPDA), Neonatal Data Analysis Unit (NDAU), Neurological Problems, NHS Atlas 3.0, NHS Atlas of Variation, NHS Atlas of Variations in Diagnostic Services, NHS Atlases of Variation, NHS Business Services Authority (NHSBSA), NHS Improving Quality (NHSIQ), NHS Manchester Immunisation Promotion Project (IPP), NHS Right Care, NHS Variations in Diagnostic Services, NHS Waiting Times, NMHDNIN: National Mental Health Dementia and Neurology Intelligence Network, Office for National Statistics, Office for National Statistics (ONS), Online InstantAtlas: NHS Atlas of Variations in Diagnostic Services, Oxfordshire Childrens Diabetes Service, PHE: Public Health England, Primary Schools Intervention Programme, Public Health England (PHE), Public Health England Learning Disabilities Observatory Team, Public Health England Obesity Knowledge and Intelligence Team, Quality Improvement, Reducing Variation, RightCare’s NHS Atlas of Variation, Royal College of Midwives (RCM), Royal College of Obstetricians and Gynaecologists (RCOG), Sentinel Stroke National Audit Programme (SSNAP), Sport England, Stroke Association, Stroke Improvement National Audit Programme (SINAP), Timely Diagnosis, Trauma Audit and Research Network (TARN), True Clinical Variation Versus Unwarranted Variation, UK Renal Registry (UKRR), Unacceptable Variations, Unwarranted Variations, Unwarranted Variations in Diagnostic Testing Rates, Value Opportunities in Local Commissioning, Variation Analysis, Variation in Commissioning, Variations in Care, Variations in Quality of Care, Waiting Times
|
Leave a comment
Limited Usefulness of MRI for Improving the Prediction of Dementia? (BMJ)
Summary Research indicates that MRI does not significantly improve the prediction of dementia. It does have some value in differential diagnosis. Full Text Link Reference Stephan, BC. Tzourio, C. [and] Auriacombe, S. [et al] (2015). Usefulness of data from magnetic … Continue reading →
Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, UK
|
Tagged Alzheimer's Disease: Diagnosis, Assessment and Diagnosis, BMJ, Bordeaux University Hospital, Brain Imaging, Brain Volume, British Medical Journal (BMJ), Cerebral Brain Volume, Dementia Diagnosis, Dementia Screening, Diagnosis of Dementia, Differential Diagnosis, Dijon Magnetic Resonance Imaging Study Cohort, Early Diagnosis, Early Screening, France, France University of Bordeaux, French Three-City Study, Grey-Matter Volume, Hippocampal Volume, Imaging, Inserm Research Centre for Epidemiology and Biostatistics (U897), Inserm: Team Epidemiology and Neuropsychology of Brain Aging, Inserm: Team Neuroepidemiology, Institute of Health and Society: Newcastle University, MRI Brain Imaging, Neuroimaging, Neuroimaging in Dementia Diagnosis, Neuroimaging of Dementia, Neuroimaging Tools, Newcastle University, Screening for Dementia, Team Neuroepidemiology (Inserm), Three-City Study, Timely Diagnosis, White Matter Lesion (WML)
|
Leave a comment
Benefits of Timely Diagnosis and Early Intervention in Dementia (BMJ)
Summary A wide-ranging literature review, clinical review and educational update on these topics. Full Text Link Reference Robinson, L. Tang, E. [and] Taylor J-P. (2015). Dementia: timely diagnosis and early intervention. BMJ. June 16th 2015; 350: h3029.
Posted in Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, National, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest
|
Tagged Additional Educational Resources, Advance Care Planning, Advance Directive for Refusal of Treatment (or “Living Will”), Alcohol-Related Dementia, Alzheimer's Society, Alzheimer’s Disease International: Help for Caregivers, Assessment and Diagnosis, AT Dementia, Barriers to Early Diagnosis, Best Practice, Best Practice for Dementia Care, BMJ, BMJ Learning (Free Resource), Brain Scans, Brief Cognitive Assessment Tools for Dementia in Primary Care, British Medical Journal (BMJ), Care Planning, Caregiver Support, Carer Support, Carer Support Services, Carers UK Factsheets, Caring for Family Carers, Corticobasal Syndrome, Creutzfeldt-Jakob Disease, Dementia with Lewy Bodies, Diagnosis: Saying The “D” Word, Frontotemporal Dementia, FTD Talk, HIV Related Cognitive Impairment, Huntington’s Chorea, Imaging, Information and Advice, Information Provision, Institute of Health and Society, Institute of Health and Society: Newcastle University, Institute of Neuroscience: Newcastle University, Lewy Body Society, Movement Related Dementias (Example: Progressive Supranuclear Palsy), Multiple Sclerosis, Newcastle University, Niemann-Pick Disease Type C, Normal-Pressure Hydrocephalus, Parkinson’s Disease With Dementia, Personalised Care Planning, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Posterior Cortical Atrophy, Power of Attorney, Prevalence of Dementia, Primary Care, Proxy Decision Making, Resources for Patients and Carers, SCIE’s Dementia Gateway, Secondary Care, Social Care Institute for Excellence: Dementia Gateway, Statement of Wishes and Preferences, Vascular Dementia
|
Leave a comment
Brief Notes on Dementia Diagnosis (NHS England)
Summary A further brief note on dementia diagnosis and post-diagnostic support, from Alistair Burns, National Clinical Director for Dementia at NHS England. Full Text Link Reference Diagnosing dementia: any appropriately skilled clinician can make the diagnosis and brain scanning not … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, Diagnosis, For Nurses and Therapists (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Person-Centred Care, Quick Insights, UK, Universal Interest
|
Tagged Alistair Burns, Alistair Burns: NHS England’s National Clinical Director for Dementia, Antipsychotics: Neuroleptic Sensitivity, Brain Imaging, Brain Scans, Dementia Diagnosis, Dementia Diagnosis and Care in England, Dementia Guidelines, Diagnosis, Diagnosis and Assessment, Diagnosis and Referral, Diagnosis and Support, Diagnosis at Primary Care Level, Differential Diagnosis, Early Diagnosis, General Practice, GPs, Imaging, Improving Dementia Diagnosis Rates, Lewy Body Dementia, MRI Scans, Neuroimaging, NICE Dementia Guideline, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Potboiler, Professor Alistair Burns, Severe Neuroleptic Sensitivity, Support for Improving Dementia Diagnosis Rates, Timely Diagnosis
|
Leave a comment
Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)
Summary This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia … Continue reading →
Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Models of Dementia Care, NIHR, Systematic Reviews, UK
|
Tagged 11C-PIB-PET, 18FDG-PET, 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test (AMT), Addenbrooke's Cognitive Exaination-Revised (ACE-R), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, APOE e4 (Apolipoprotein E e4), APOE-4 Allele, Asymptomatic Alzheimer’s Disease, Blessed Information-Memory-Concentration Test (Blessed I-M-C), Brain Imaging, Bristol University, Canada, CDCIG: Cochrane Dementia and Cognitive Improvement Group, Central and North West London NHS Foundation Trust, China, China Medical University, Clinical Cooperation Unit Nuclear Medicine (Heidelberg), Clock Drawing Test (CDT), Cochrane Dementia and Cognitive Improvement Group (CDCIG), Cochrane Diagnostic Test Accuracy (DTA) Dementia Reviews, Cochrane Diagnostic Test Accuracy (DTA) Reviews, Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit), Cognitive Assessments / Screening Tools, CSF (Cerebrospinal Fluid Analysis of Amyloid Beta and Tau), CSF Tau, CSF Tau / ABeta Ratio, Department of Neurology: VU University Medical Centre Amsterdam, Devon, Diagnostic Test Accuracy (DTA) Handbook, Diagnostic Test Accuracy Reviews, Differential Diagnosis, Differential Diagnosis of Alzheimer’s Disease, Dopamine Transporter Imaging, Dopamine Transporter Imaging (for Diagnosis of DLB), DTA Handbook, Early Differential Diagnosis, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta: Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, FP-CIT (Fluoropropyl-Carbomethoxy-3b-(4-Iodophenyl)Tropane), Frenchay Hospital (Bristol), Frontotemporal Dementia (FTD), Generic Protocols for Cross-Sectional and Delayed-Verification Studies, German Cancer Research Center: Medical PET Group - Biological Imaging, Germany, Glasgow Royal Infirmary, GP-Cog, Imaging, Imperial College London, Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Institute of Cardiovascular and Medical Sciences: Glasgow, Institute of Cardiovascular and Medical Sciences: University of Glasgow, Institute of Health Research: Exeter, Institute of Public Health (Cambridge UK), Institute of Public Health (IPH), Institute of Public Health: Cambridge, IRCCS Fatebenefratelli (Brescia), Italy, John Radcliffe Hospital, LITA Polo Universitario, Maastricht University, Maastricht University: Department of Psychiatry and Neuropsychology, Mini-Cog, Modified Mini-Mental State Examination (3-MS), MRI, MRI Brain Imaging, MRI Scans, National Institute for Health Research (NIHR) Cochrane Collaboration Programme, Netherlands, Neuroimaging in Dementia Diagnosis, Neuropsychological Tests for Alzheimer’s Disease Diagnosis, Neuropsychological Tests for Dementia Diagnosis, North Bristol NHS Trust, Nuffield Department of Clinical Neurosciences (Oxford), Nuffield Department of Clinical Neurosciences: University of Oxford, Nuffield Department of Medicine (Oxford), Older People and Healthy Ageing Service Line (London), OPTIMA (Oxford Project to Investigate Memory and Ageing), OPTIMA (Oxfordshire UK), Ospedale Luigi Sacco, Oxford, Oxford Health NHS Foundation Trust, Oxford University Hospitals NHS Trust, Oxford University Medical School, PenCLAHRC, Peninsula CLAHRC, Peninsula Technology Assessment Group (PenTAG), PET-FDG (Positron Emission Tomography F-Fluorodeoxyglucose), PET-PiB (Positron Emission Tomography-Pittsburgh Compound B), Plasma and Cerebrospinal Fluid (CSF) Abeta42, Positron Emission Tomography (PET), Protocols, Public Health Epidemiology and Biostatistics: Birmingham, Queen's University (Canada), Radcliffe Department of Medicine, ratio, rCBF SPECT, Research Protocol, School for Mental Health and Neuroscience: Maastricht University, Shengjing Hospital, sMRI (Structural Magnetic Resonance Imaging), SPECT (Single Photon Emission Computed Tomography), St Louis University Mental Status Examination (SLUMS), Study Protocol, Sunnybrook Health Sciences Centre (Toronto), Systematic Reviews and Meta-Analyses, Test Your Memory (TYM), University Hospitals Bristol, University of Birmingham, University of Bristol, University of Cambridge, University of Exeter, University of Exeter Medical School, University of Glasgow, University of Milan, University of Oxford, University of Toronto, VU University (Netherlands), VU University Medical Centre
|
Leave a comment
